Medicines That Kill


Book Description

The recent deaths of celebrities like Michael Jackson, Anna Nicole Smith, Heath Ledger, and Whitney Houston have shown a spotlight on the overuse and abuse of prescription drugs. Most people believe that prescription drugs are safer than illegal substances. But, when combined with other over-the-counter sedatives, prescription drugs can be every bit as powerful, addictive, and dangerous. In 2006, overdoses on a class of prescription pain relievers called opioid analgesics killed more people than those killed by overdoses on cocaine and heroin combined. Right now, among 35 to 54 year olds, poisoning by prescription drugs is the most common cause of accidental death—even more so than auto-related deaths. In Medicines That Kill, Dr. Marcum shines a light on the addictive power of prescription medication and how you can protect yourself and your family by practicing healthy habits.




Are Your Prescriptions Killing You?


Book Description

A veteran board-certified pharmacist cites the high number of annual deaths associated with prescription drug side effects, calling for changes in prescription practices that account for the needs of aging bodies.




A Prescription for Murder


Book Description

McLaren develops a historiographical survey on Victorian attitudes toward sexuality and morality, and their relation to violence as he describes the story of Dr. Thomas Cream. Cream murdered prostitutes and women seeking abortions in England and North America between 1877 and 1892.




Death By Prescription


Book Description

Experienced family doctor Ray Strand writes his patients prescriptions every week, but he also believes that prescribing drugs should be a last resort in most medical cases-not a first choice. In Death by Prescription he provides simple guidelines to help readers protect themselves and their families from suffering adverse reactions to prescription medication.




Harold Shipman - Prescription For Murder


Book Description

He was a pillar of the community, serving on local committees, donating prizes to the rugby club, organising charity collections. His patients thought the world of him: he was attentive, kind, never too busy to chat. Yet Dr Harold Frederick Shipman was also the most prolific serial killer the world has ever known, with between 200 and 300 victims. Quietly, for many years, the small, bespectacled GP was making unexpected house calls - and walking out leaving a dead body behind. The murderous career of Dr Shipman only came to an end when police in Hyde, Greater Manchester, were called to investigate a forged will. Overnight, they found themselves embroiled in the biggest murder case in British history. Substantially revised and updated since Shipman's suicide in prison, this is a compelling account of these monstrous crimes and of the man who committed them. The authors have had unparalleled access to friends, colleagues and patients. Their in-depth and authoritative investigation looks at how he killed, how he was able to get away with it for so long, and - most important of all - why.




Case Studies in Pharmacy Ethics


Book Description

Pharmacists face ethical choices constantly -- sometimes dramatic life-and-death decisions, but more often subtle, less conspicuous choices that are nonetheless important. Among the topics confronted are assisted suicide, conscientious refusal, pain management, equitable distribution of drug resources within institutions and managed care plans, confidentiality, and alternative and non-traditional therapies. Veatch and Haddad's book, first published in 1999, was the first collection of case studies based on the real experiences of practicing pharmacists, for use as a teaching tool for pharmacy students. The second edition accounts for the many changes in pharmacy since 1999, including assisted suicide in Oregon, the purchasing of less expensive drugs from Canada, and the influence of managed care on prescriptions. The presentation of some cases is shortened, most are revised and updated, and two new chapters have been added. The first new chapter presents a new model for analyzing cases, while the second focuses on the ethics of new drug distribution systems, for example hospitals where pharmacists are forced to choose drugs based on cost-effectiveness, and internet based pharmacies.




Prescription for Disaster


Book Description

This hard-hitting expose does for prescription drugs what "Silent Spring" did for pesticides, revealing the hidden dangers of the most commonly prescribed medications--and what the consumer can do to minimize the risks of serious side effects.




Pain Killer


Book Description

Examines OxyContin, the so-called miracle prescription drug that swept the nation but led to overdoes and addiction, providing a look at the multi-billion-dollar pain managment business, its excesses and its abuses.




Prescription to Kill


Book Description

In a large teaching hospital in Dallas, Texas, the neurosurgery department has the usual mix of new and old interns with their usual mix of problems but it also has a couple of unexpected and unexplained deaths.




Pain Management and the Opioid Epidemic


Book Description

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.